Is a complete NSE/MEDPLUS research report available?

No complete published report is available for nse/MEDPLUS (NSE/MEDPLUS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

nse/MEDPLUS stock profile: metrics, valuation and analysis

Market cap	79.3B
Revenue (ttm)	72.3B
Net income (ttm)	2.1B
EPS (ttm)	₹17.5
Shares out	120.1M
P/E (trailing)	37.7x
P/E (forward)	36.4x
Volume	150,921
Beta	0.46

All NSE/MEDPLUS indicators

Market & fundamental data

Available fields

201

Groups with data

Currency

INR

Showing 201 of 201 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	28,872
Employees Change	3,865%
Employees Change Percent	15.46
Enterprise value	INR 87.4B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Pharmaceutical Retailers
Isin	INE804L01022
Last refreshed	2026-09-08
Market cap	INR 79.3B
Price	INR 660
Price currency	INR
Rev Per Employee	2,503,959.55x
Sector	Healthcare
Sector PE	47.68
Sector PE Fwd	38.22
Sic	5912
Symbol	nse/MEDPLUS
Website	https://www.medplusindia.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.66%
EV Earnings	41.51x
EV/EBIT	27.76x
EV/EBITDA	14.59x
EV/FCF	23.45x
EV/Sales	1.21x
FCF yield	4.7%
Forward P/E	36.41x
P/B ratio	4.01x
P/E ratio	37.66x
P/S ratio	1.1x
PE Ratio3 Y	83.75x
PE Ratio5 Y	114.03x
PEG ratio	1.92x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	4.35%
EBITDA Margin	5.46%
FCF margin	5.41%
Gross margin	25.8%
Gross Profit	INR 18.7B
Gross Profit Growth	18.88%
Gross Profit Growth Q	14.25%
Gross Profit Growth3 Y	20.62%
Gross Profit Growth5 Y	21.92%
Net Income	INR 2.1B
Net Income Growth	18.03%
Net Income Growth Q	-21.68%
Net Income Growth Qo Q	-48.11%
Net Income Growth Years	3%
Net Income Growth3 Y	61.09%
Net Income Growth5 Y	16.25%
Pretax Margin	3.66%
Profit Margin	2.91%
Profit Per Employee	INR 72,897
Profitable Quarters	INR 25
Profitable Years	8
Roa5y	4.19
Roe5y	7.48
ROIC	8.96
Roic5y	7.29

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-20.77%
Cagr3y	-6.96%
EPS Growth	18.03
EPS Growth Q	-21.81
EPS Growth Qo Q	-48.18
EPS Growth Years	3
EPS Growth3 Y	60.7
EPS Growth5 Y	14.12
FCF Growth	-22.54%
OCF Growth	-8.3%
OCF Growth3 Y	76.32%
OCF Growth5 Y	179.76%
Revenue Growth	16.8x
Revenue Growth Q	21.84x
Revenue Growth Qo Q	0.82x
Revenue Growth Quarters	25x
Revenue Growth Years	7x
Revenue Growth3 Y	14.25x
Revenue Growth5 Y	17.03x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 6.1B
Debt	INR 14.2B
Debt EBITDA	INR 2.38
Debt Equity	INR 0.72
Debt FCF	INR 3.82
Equity	INR 19.7B
Interest Coverage	2.49
Net Cash	INR -8.1B
Net Cash By Market Cap	INR -10.24
Net Debt EBITDA	INR 2.05
Net Debt Equity	INR 0.41
Net Debt FCF	INR 2.18
Tangible Book Value	INR 19.3B
Tangible Book Value Per Share	INR 160
WACC	6.82

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-20.76%
200-day SMA	813.3
3Y total return	-19.46%
50-day SMA	725.3
50-day SMA vs 200-day SMA	50under200
All Time High	1,343
All Time High Change	-50.88%
All Time High Date	2022-01-20
All Time Low	548.3
All Time Low Change	20.33%
All Time Low Date	2022-12-01
ATR	20.44
Beta	0.46
Beta1y	-0
Beta2y	-0.1
Ch YTD	-18.28
High	672.1
High52	1,022.2
High52 Date	2026-05-21
High52ch	-35.46%
Low	656.6
Low52	648
Low52 Date	2026-09-03
Low52ch	1.81%
Ma50ch	-9.04%
Price vs 200-day SMA	-18.88%
RSI	39.46
RSI Monthly	38.86
RSI Weekly	31.07
Sharpe ratio	-0.76x
Sharpe Ratio3y	-0.34x
Sortino ratio	-0.85
Sortino Ratio3y	-0.3
Total Return	-0%
Tr YTD	-18.28
Tr1m	-4.42%
Tr1w	-1.87%
Tr3m	-23.17%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	71,244,686%
Net Borrowing	-1,449,420,000
Shares Insiders	13.29%
Shares Institutions	45.03%
Shares Out	120,135,000
Shares Qo Q	0.13%
Shares Yo Y	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	INR 3.7B
Adjusted OCF	4,925,340,000
Average Volume	208,138.9x
Bv Per Share	164.6
CAPEX	INR -1.2B
Ch1m	-4.42
Ch1w	-1.87
Ch1y	-20.76
Ch3m	-23.17
Ch3y	-19.46
Ch6m	-21.6
Change	-2.46%
Change From Open	-1.54
Close	676.4
Days Gap	-0.94
Depreciation Amortization	803,067,500
Dollar Volume	99,562,583.7
Earnings Date	2026-10-27
EBIT	INR 3.1B
EBITDA	INR 4B
EPS	INR 17.52
F Score	4
FCF	INR 3.7B
FCF EV Yield	4.26x
FCF Per Share	INR 31.01
Financing CF	-2,555,050,000
Fiscal Year End	March
Founded	2,006
Graham Number	254.67456
Graham Upside	-61.4
Income Tax	INR 540.1M
Investing CF	-1,277,170,000
Is Primary Listing	1
Last Earnings Date	2026-07-21
Last Report Date	2026-06-30
Lynch Fair Value	INR 285
Lynch Upside	-56.86
Ma150	815.5
Ma150ch	-19.1%
Ma20	671.1
Ma20ch	-1.69%
Net CF	1,123,600,000
Next Earnings Date	2026-10-27
Open	670
P FCF Ratio	21.27
P FCF Ratio SBC	21.45
P OCF Ratio	15.99
P OCF Ratio SBC	16.09
Position In Range	20.32
Price Date	2026-09-07
Price EBITDA	INR 20.06
Ptbv Ratio	4.11
Relative Volume	0.73x
Revenue	72,294,320,000x
SBC By Revenue	0.04x
Share Based Comp	30,470,000
Tax By Revenue	0.75x
Tax Rate	20.42%
Tr6m	-21.6%
Volume	150,921

NSE/MEDPLUS (NSE/MEDPLUS)

Price

Financial snapshot

Fair-value bridge

Latest news · NSE/MEDPLUS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NSE/MEDPLUS indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on NSE/MEDPLUS

Frequently asked questions